Phase I/II study of paclitaxel/cisplatin as first-line therapy for locally advanced head and neck cancer

Seminars in Oncology

Volumn 24, Issue 6 SUPPL. 19, 1997, Pages

  Hitt, R ^a   Paz Ares, L ^a   Hidalgo, M ^a   Colomer, R ^a   Brandariz, A ^a   Pena, M ^a   Alvarez Vicent, J ^a   Hornedo, J ^a   Cortes Funes, H ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DIPHENHYDRAMINE; GRANULOCYTE COLONY STIMULATING FACTOR; PACLITAXEL; PREDNISONE;

ADULT; ADVANCED CANCER; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW TOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NAUSEA; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; VOMITING;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; GRANULOCYTE COLONY-STIMULATING FACTOR; HEAD AND NECK NEOPLASMS; HUMANS; MIDDLE AGED; PACLITAXEL; SURVIVAL RATE;

EID: 0031446015     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)